Colonial Trust Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $93.5K | Hold |
210
| – | – | 0.01% | 266 |
|
|
2025
Q1 | $102K | Buy |
210
+50
| +31% | +$24.2K | 0.01% | 258 |
|
|
2024
Q4 | $64.4K | Hold |
160
| – | – | 0.01% | 285 |
|
|
2024
Q3 | $74.4K | Sell |
160
-100
| -38% | -$46.5K | 0.01% | 291 |
|
|
2024
Q2 | $122K | Sell |
260
-19
| -7% | -$8.91K | 0.01% | 229 |
|
|
2024
Q1 | $117K | Buy |
279
+3
| +1% | +$1.25K | 0.01% | 230 |
|
|
2023
Q4 | $112K | Buy |
276
+245
| +790% | +$99.7K | 0.01% | 227 |
|
|
2023
Q3 | $10.8K | Hold |
31
| – | – | ﹤0.01% | 505 |
|
|
2023
Q2 | $10.9K | Buy |
31
+15
| +94% | +$5.28K | ﹤0.01% | 513 |
|
|
2023
Q1 | $5.04K | Sell |
16
-5
| -24% | -$1.58K | ﹤0.01% | 618 |
|
|
2022
Q4 | $6.06K | Buy |
+21
| New | +$6.06K | ﹤0.01% | 589 |
|